ARCHIVES

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

For NCI ; Scharff Succeeds Eagle At Einstein

September 25, 1987

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Year 2000 Objectives In Health On Track

June 25, 1999

NCI Clarifies Policy On Small, Short-Term Research Grants

July 5, 1996

NCI’s Problems With FDA Appear To Be Resolved With Agreement on Drug Distribution System

August 26, 1977

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999